Effects of resveratrol on female reproductive system malignant tumors

Journal of Dalian Medical University

Volumn 37, Issue 4, 2015, Pages 403-407

  Zhang, Peng ^a   Sun, Yuan ^a   Yao, Yuan Yuan ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

Cervical cancer; Endometrial cancer; Female reproductive system malignant tumors; Ovarian cancer; Resveratrol

Indexed keywords

RESVERATROL;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; DISTANT METASTASIS; FEMALE GENITAL TRACT CANCER; HUMAN; MALIGNANT NEOPLASTIC DISEASE; QUALITY OF LIFE; TUMOR INVASION; WOMEN'S HEALTH;

EID: 84949996085     PISSN: 16717295     EISSN: None     Source Type: Journal    
DOI: 10.11724/jdmu.2015.04.23     Document Type: Article

References (33)

1. Schrauwen P, Timmers S. Can resveratrol help to maintain metabolic health? [J]. Proc Nutr Soc, 2014, 73(2):271-277.
2. Sales JM, Resurreccion AV. Resveratrol in peanuts [J]. Crit Rev Food Sci Nutr, 2014, 54(6):734-770.
3. Kma L. Synergistic effect of resveratrol and radiotherapy in control of cancers[J]. Asian Pac J Cancer Prev, 2013, 14(11):6197-6208.
4. Picconi MA. Human papillomavirus detection in cervical cancer prevention [J]. Medicina, 2013, 73(6):585-596.
5. Peirson L, Fitzpatrick-Lewis D, Ciliska D, et al. Screening for cervical cancer; a systematic review and meta - analysis[J]. Syst Rev, 2013, 2:35.
6. Zhang P, Li H, Yang B, et al. Biological significance and therapeutic implication of resveratrol - inhibited Wnt, Notch and STAT3 signaling in cervical cancer cells [J]. Genes Cancer, 2014, 5(5-6):154-164.
7. Dhandayuthapani S, Marimuthu P, Hrmann V, et al. Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein[J]. J Med Food, 2013, 16(2):139-146.
8. Shi YH, Tuokan T, Lin C, et al. Aquaporin 8 involvement in human cervical cancer SiHa migration via the EGFR - Erkl/2 pathway[J]. Asian Pac J Cancer Prev, 2014, 15(15):6391-6395.
9. García-Zepeda SP, García-Villa E, Díaz-Chávez J, et al. Resveratrol induces cell death in cervical cancer cells through apoptosis and autophagy [J]. Eur J Cancer Prev, 2013, 22(6):577-584.
10. Carnielli CM, Winck FV, Paes Leme AF. Functional annotation and biological interpretation of proteomics data [J]. Biochim Biophys Acta, 2015, 1854(1):46-54.
11. Dhandayuthapani S, Marimuthu P, Hrmann V, et al. Induction of apoptosis in HeLa cells via caspase activation by resveratrol and genistein[J]. J Med Food, 2013, 16(2):139-146.
12. Suba EJ, Raab SS. Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the socialist republic of Vietnam[J]. Diagn Cytopathol, 2012, 40(4):355-366.
13. Lynne Gaffikin, John A McGrath, Marc Arbyn, et al. Visual inspection with acetic acid as a cervical cancer test: accuracy validated using latent class analysis [J]. BMC Med Res Methodol, 2007, 7:36.
14. Kim YS, Sull JW, Sung HJ. Suppressing effect of resveratrol on the migration and invasion of human metastatic lung and cervical cancer cells [J]. Mol Biol Rep, 2012, 39(9):8709-8716.
15. Westin SN, Broaddus RR. Personalized therapy in endometrial cancer; Challenges and opportunities[J]. Cancer BiolTher, 2012, 13(1):1-13.
16. Dann JM, Sykes PH, Mason DR, et al. Regulation of vascular endothelial growth factor in endometrial tumour cells by resveratrol and EGCG [J]. Gynecol Oncol, 2009, 113(3):374-378.
17. Bhat KP, Pezzuto JM. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells [J]. Cancer Res, 2001, 61(16):6137-6144.
18. Cheung CH, Huang CC, Tsai FY, et al. Survivin - biology and potential as a therapeutic target in oncology [J]. Onco Targets Ther, 2013, 6:1453-1462.
19. Evans JJ, Chitcholtan K, Dann JM, et al. Adrenomedullin interacts with VEGF in endometrial cancer and has varied modulation in tumours of different grades[J]. Gynecol Oncol, 2012, 25(1):214-219.
20. Sexton E, Van Themsche C, LeBlanc K, et al. Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells [J]. Mol Cancer, 2006, 5:45.
21. Sarkar FH, Li Y, Wang Z, et al. Cellular signaling perturbation by natural products[J]. Cell Signal, 2009, 21(11):1541-1547.
22. Eftekhar M, Pourmasumi S, Karimi-Zarchi M. Preservation of ovarian function during chemotherapy and radiotherapy in young women with malignancies[J]. Iran J Reprod Med, 2014, 12(6):377-382.
23. Shiozaki T, Tabata T, Yamada T, et al. Does positive peritoneal cytology not affect the prognosis for stage I uterine endometrial cancer?; the remaining controversy and review of the literature[J]. Int J Gynecol Cancer, 2014, 24(3):549-555.
24. Bhat KP, Pezzuto JM. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells [J]. Cancer Res, 2001, 61(16):6137-6144.
25. Sbastien Baribeau, Parvesh Chaudhry, Sophie Parent, et al. Resveratrol inhibits cisplatin - induced epithelial - to - mesenchymal transition in ovarian cancer cell lines [J]. PLoS One, 2014, 9(1):e86987.
26. Ding S, Li L, Yu C. Systematic evaluation of bevacizumab in recurrent ovarian cancer treatment [J]. J BUON, 2014, 19(4):965-972.
27. Piotrowska H, Myszkowski K, Ziółkowska A, et al. Resveratrol analogue 3, 4, 4', 5 - tetramethoxystilbene inhibits growth, arrests cell cycle and induces apoptosis in ovarian SKOV-3 and A-2780 cancer cells [J]. Toxicol Appl Pharmacol, 2012, 263(1):53-60.
28. Nessa MU, Beale P, Chan C, et al. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells[J]. Anticancer Res, 2012, 32(1):53-59.
29. Hoekstra A, Rodriguez GC. Chemoprevention of ovarian cancer[J]. Cancer Treat Res, 2009, 149; 3-34.
30. Tyagi A, Singh RP, Agarwal C, et al. Resveratrol causes Cdc2 - tyrl5 phosphorylation via ATM/ATR - Chkl/2 - Cdc25C pathway as a central mechanism for S phase arrest in human ovariancarcinoma Ovcar - 3 cells [J]. Carcinogenesis, 2005, 26(11):1978-1987.
31. Kang NH, Hwang KA, Kim TH, et al. Induced growth of BG - 1 ovarian cancer cells by 17β - estradiol or various endocrine disrupting chemicals was reversed by resveratrol via downregulation of cell cycle progression[J]. Mol Med Rep, 2012, 6(1):151-156.
32. Mikuła-Pietrasik J, Sosińska P, Ksiązek K, et al. Resveratrol inhibits ovarian cancer cell adhesion to peritoneal mesothelium in vitro by modulating the production of α5βl integrins and hyaluronic acid[J]. Gynecol Oncol, 2014, 134(3):624-630.
33. Marimuthu P, Kaur K, Kandalam U, et al. Treatment of ovarian cancer cells with nutlin - 3 and resveratrol combination leads to apoptosis via caspase activation[J]. J Med Food, 2011, 4(1-2):46-52.